Search

Brian E. Mcdowell

Examiner (ID: 17098, Phone: (571)270-5755 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
4161, 1624
Total Applications
1657
Issued Applications
1038
Pending Applications
129
Abandoned Applications
533

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5458730 [patent_doc_number] => 20090258882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => '2,4-Substituted Quinazolines as Lipid Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/375450 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32461 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258882.pdf [firstpage_image] =>[orig_patent_app_number] => 12375450 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/375450
2,4-Substituted Quinazolines as Lipid Kinase Inhibitors Jul 24, 2007 Abandoned
Array ( [id] => 7811381 [patent_doc_number] => 08133912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Methyl aquocobyrinic acid derivative, alkylation composition, and method for detoxifying a harmful compound by utilizing the composition' [patent_app_type] => utility [patent_app_number] => 12/309511 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 11313 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133912.pdf [firstpage_image] =>[orig_patent_app_number] => 12309511 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/309511
Methyl aquocobyrinic acid derivative, alkylation composition, and method for detoxifying a harmful compound by utilizing the composition Jul 23, 2007 Issued
Array ( [id] => 5490872 [patent_doc_number] => 20090291943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/373194 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5079 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291943.pdf [firstpage_image] =>[orig_patent_app_number] => 12373194 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/373194
Process for preparing diaminophenothiazinium compounds Jul 11, 2007 Issued
Array ( [id] => 5297362 [patent_doc_number] => 20090012288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Process for preparation of pentostatin (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz[4,5-d][1,3] diazepin-8-ol' [patent_app_type] => utility [patent_app_number] => 11/822177 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2323 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012288.pdf [firstpage_image] =>[orig_patent_app_number] => 11822177 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/822177
Process for preparation of pentostatin (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz[4,5-d][1,3] diazepin-8-ol Jul 2, 2007 Abandoned
Array ( [id] => 6545236 [patent_doc_number] => 20100016293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use' [patent_app_type] => utility [patent_app_number] => 12/307197 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11558 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016293.pdf [firstpage_image] =>[orig_patent_app_number] => 12307197 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/307197
Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use Jul 2, 2007 Abandoned
Array ( [id] => 6598841 [patent_doc_number] => 20100292229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'TRYPHOSTIN-ANALOGS FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/307088 [patent_app_country] => US [patent_app_date] => 2007-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 28669 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292229.pdf [firstpage_image] =>[orig_patent_app_number] => 12307088 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/307088
TRYPHOSTIN-ANALOGS FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES Jul 1, 2007 Abandoned
Array ( [id] => 4910257 [patent_doc_number] => 20080021024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Metalloprotease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/824525 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26798 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021024.pdf [firstpage_image] =>[orig_patent_app_number] => 11824525 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/824525
Metalloprotease inhibitors Jun 28, 2007 Abandoned
Array ( [id] => 4910443 [patent_doc_number] => 20080021210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'COMPOSITIONS AND METHODS OF MAKING A PHOTOACTIVE AGENT' [patent_app_type] => utility [patent_app_number] => 11/772024 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6831 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021210.pdf [firstpage_image] =>[orig_patent_app_number] => 11772024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/772024
Compositions and methods of making a photoactive agent Jun 28, 2007 Issued
Array ( [id] => 5279318 [patent_doc_number] => 20090131450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'USE OF PKC INHIBITORS IN DIABETIC COMPLICATIONS' [patent_app_type] => utility [patent_app_number] => 12/305249 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7004 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131450.pdf [firstpage_image] =>[orig_patent_app_number] => 12305249 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/305249
USE OF PKC INHIBITORS IN DIABETIC COMPLICATIONS Jun 27, 2007 Abandoned
Array ( [id] => 4803608 [patent_doc_number] => 20080015197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Process for the preparatrion of zopiclone' [patent_app_type] => utility [patent_app_number] => 11/823345 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5085 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015197.pdf [firstpage_image] =>[orig_patent_app_number] => 11823345 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/823345
Process for the preparatrion of zopiclone Jun 25, 2007 Abandoned
Array ( [id] => 4853221 [patent_doc_number] => 20080318964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'DEUTERIUM-ENRICHED ESZOPICLONE' [patent_app_type] => utility [patent_app_number] => 11/765435 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4273 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318964.pdf [firstpage_image] =>[orig_patent_app_number] => 11765435 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/765435
DEUTERIUM-ENRICHED ESZOPICLONE Jun 18, 2007 Abandoned
Array ( [id] => 4658201 [patent_doc_number] => 20080027063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/758243 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25255 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027063.pdf [firstpage_image] =>[orig_patent_app_number] => 11758243 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/758243
Imidazopyrazines as protein kinase inhibitors Jun 4, 2007 Issued
Array ( [id] => 5231401 [patent_doc_number] => 20070293509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Pyrazinecarboxamide derivatives as CB1 antagonists' [patent_app_type] => utility [patent_app_number] => 11/809047 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21598 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293509.pdf [firstpage_image] =>[orig_patent_app_number] => 11809047 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/809047
Pyrazinecarboxamide derivatives as CB1 antagonists May 29, 2007 Issued
Array ( [id] => 4710689 [patent_doc_number] => 20080299215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'DEUTERIUM-ENRICHED LESTAURTINIB' [patent_app_type] => utility [patent_app_number] => 11/754390 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3718 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299215.pdf [firstpage_image] =>[orig_patent_app_number] => 11754390 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/754390
DEUTERIUM-ENRICHED LESTAURTINIB May 28, 2007 Abandoned
Array ( [id] => 285538 [patent_doc_number] => 07550465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them' [patent_app_type] => utility [patent_app_number] => 11/753207 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 8 [patent_no_of_words] => 16229 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550465.pdf [firstpage_image] =>[orig_patent_app_number] => 11753207 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/753207
Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them May 23, 2007 Issued
Array ( [id] => 4910277 [patent_doc_number] => 20080021044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'N-[2-[[(DIAMINOMETHYLENE)AMINO]OXY]ETHYL]-3-[(2,2-DIFLUORO-2-PHENYLETHYL)AMINO]-6-METHYL-2-OXO-1(2H)-PYRAZINEACETAMIDE' [patent_app_type] => utility [patent_app_number] => 11/751155 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15777 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021044.pdf [firstpage_image] =>[orig_patent_app_number] => 11751155 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/751155
N-[2-[[(DIAMINOMETHYLENE)AMINO]OXY]ETHYL]-3-[(2,2-DIFLUORO-2-PHENYLETHYL)AMINO]-6-METHYL-2-OXO-1(2H)-PYRAZINEACETAMIDE May 20, 2007 Abandoned
Array ( [id] => 4670421 [patent_doc_number] => 20080045481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'NOVEL CO-CRYSTAL' [patent_app_type] => utility [patent_app_number] => 11/748651 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15287 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045481.pdf [firstpage_image] =>[orig_patent_app_number] => 11748651 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/748651
Co-crystal May 14, 2007 Issued
Array ( [id] => 4509070 [patent_doc_number] => 07915409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Organometal complex and light-emitting element using the same' [patent_app_type] => utility [patent_app_number] => 11/797532 [patent_app_country] => US [patent_app_date] => 2007-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 10795 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915409.pdf [firstpage_image] =>[orig_patent_app_number] => 11797532 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/797532
Organometal complex and light-emitting element using the same May 3, 2007 Issued
Array ( [id] => 228903 [patent_doc_number] => 07601716 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors' [patent_app_type] => utility [patent_app_number] => 11/799066 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84793 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601716.pdf [firstpage_image] =>[orig_patent_app_number] => 11799066 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/799066
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors Apr 29, 2007 Issued
Array ( [id] => 8896737 [patent_doc_number] => 08476258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same' [patent_app_type] => utility [patent_app_number] => 12/298564 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5069 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12298564 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/298564
Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same Apr 25, 2007 Issued
Menu